M. Jane Ehrke

1.8k total citations
69 papers, 1.5k citations indexed

About

M. Jane Ehrke is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, M. Jane Ehrke has authored 69 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 26 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in M. Jane Ehrke's work include Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (15 papers) and Immune Response and Inflammation (12 papers). M. Jane Ehrke is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (15 papers) and Immune Response and Inflammation (12 papers). M. Jane Ehrke collaborates with scholars based in United States, Slovakia and France. M. Jane Ehrke's co-authors include Enrico Mihich, Darbie Maccubbin, Stefan A. Cohen, Kenneth Mace, Peter Ujházy, Erica S. Berleth, Srđan Verstovšek, Kazuo Ryoyama, Michael J. Mastrangelo and David Berd and has published in prestigious journals such as Nucleic Acids Research, The Journal of Immunology and Cancer Research.

In The Last Decade

M. Jane Ehrke

69 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Jane Ehrke United States 22 713 539 478 107 104 69 1.5k
Livia Di Renzo Italy 24 443 0.6× 446 0.8× 526 1.1× 140 1.3× 60 0.6× 51 1.6k
Françoise Besançon France 22 561 0.8× 333 0.6× 1.1k 2.2× 37 0.3× 67 0.6× 53 1.9k
Thuy‐Anh Tran‐Thi Germany 20 298 0.4× 179 0.3× 583 1.2× 42 0.4× 64 0.6× 32 1.5k
Chung‐Her Jenh United States 17 400 0.6× 793 1.5× 755 1.6× 27 0.3× 47 0.5× 30 1.7k
Long T. Quan United States 5 580 0.8× 548 1.0× 2.0k 4.1× 46 0.4× 26 0.3× 6 2.6k
David Fischer United States 19 208 0.3× 318 0.6× 953 2.0× 31 0.3× 178 1.7× 36 1.6k
S Scott United States 11 455 0.6× 131 0.2× 586 1.2× 28 0.3× 33 0.3× 13 1.6k
Bassam B. Damaj United States 19 665 0.9× 322 0.6× 553 1.2× 28 0.3× 27 0.3× 30 1.4k
Jean‐Pierre Kolb France 20 568 0.8× 187 0.3× 507 1.1× 23 0.2× 34 0.3× 35 1.5k
Gerald Ranges United States 23 1.4k 1.9× 554 1.0× 785 1.6× 44 0.4× 12 0.1× 37 2.7k

Countries citing papers authored by M. Jane Ehrke

Since Specialization
Citations

This map shows the geographic impact of M. Jane Ehrke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Jane Ehrke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Jane Ehrke more than expected).

Fields of papers citing papers by M. Jane Ehrke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Jane Ehrke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Jane Ehrke. The network helps show where M. Jane Ehrke may publish in the future.

Co-authorship network of co-authors of M. Jane Ehrke

This figure shows the co-authorship network connecting the top 25 collaborators of M. Jane Ehrke. A scholar is included among the top collaborators of M. Jane Ehrke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Jane Ehrke. M. Jane Ehrke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ujházy, Peter, et al.. (2003). Doxorubicin induces specific immune functions and cytokine expression in peritoneal cells. Cancer Immunology Immunotherapy. 52(7). 463–472. 41 indexed citations
2.
Ehrke, M. Jane. (2003). Immunomodulation in cancer therapeutics. International Immunopharmacology. 3(8). 1105–1119. 86 indexed citations
3.
Ehrke, M. Jane, Srđan Verstovšek, Darbie Maccubbin, et al.. (2000). Protective specific immunity induced by doxorubicin plus TNF-α combination treatment of EL4 lymphoma-bearing C57BL/6 mice. International Journal of Cancer. 87(1). 101–109. 23 indexed citations
4.
Mihich, Enrico & M. Jane Ehrke. (2000). Anticancer drugs plus cytokines: immunodulation based therapies of mouse tumors. International Journal of Immunopharmacology. 22(12). 1077–1081. 13 indexed citations
5.
Berleth, Erica S., Hira L. Gurtoo, Robert M. Wollman, et al.. (2000). A novel tumor necrosis factor-α inhibitory protein, TIP-B1. International Journal of Immunopharmacology. 22(12). 1137–1142. 15 indexed citations
6.
Nadadur, Srikanth S., M. Jane Ehrke, & Hira L. Gurtoo. (1999). A novel TNF-inducible message with putative growth suppressor function. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1489(2-3). 433–439. 1 indexed citations
7.
Berleth, Erica S., et al.. (1999). Measurement of low-abundance cytokine mRNA in cells of murine lymphoid organs: a new quantitative reverse transcription/polymerase chain reaction method. Cancer Immunology Immunotherapy. 48(8). 471–481. 2 indexed citations
8.
Ehrke, M. Jane, Srđan Verstovšek, Peter Ujházy, et al.. (1998). Doxorubicin plus tumor necrosis factor α combination treatments in EL4-lymphoma-bearing C57BL/6 mice. Cancer Immunology Immunotherapy. 45(6). 287–298. 14 indexed citations
9.
Ujházy, Peter, Erica S. Berleth, Haruhisa Kitano, et al.. (1996). Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistance. International Journal of Cancer. 68(4). 493–500. 68 indexed citations
10.
Ehrke, M. Jane, et al.. (1996). Specific anti-EL4-lymphoma immunity in mice cured 2 years earlier with doxorubicin and interleukin-2. Cancer Immunology Immunotherapy. 42(4). 221–230. 14 indexed citations
11.
Ehrke, M. Jane, et al.. (1995). Cyclophosphamide plus tumor necrosis factor‐α chemoimmunotherapy cured mice: Life‐long immunity and rejection of re‐implanted primary lymphoma. International Journal of Cancer. 63(3). 463–471. 19 indexed citations
12.
Verstovšek, Srđan, et al.. (1995). Protective specific immunity induced by cyclophosphamide plus tumor necrosis factor α combination treatment of EL4-lymphoma-bearing C57BL/6 mice. Cancer Immunology Immunotherapy. 40(6). 347–357. 15 indexed citations
13.
Ujházy, Peter, et al.. (1994). Ecto‐5'‐nucleotidase (CD73) in multidrug‐resistant cell lines generated by doxorubicin. International Journal of Cancer. 59(1). 83–93. 38 indexed citations
14.
Berleth, Erica S., Bruce J. Dolnick, M. Jane Ehrke, & Enrico Mihich. (1994). RNA recovery efficiency for cultured cells and organ-derived cell suspensions. Nucleic Acids Research. 22(10). 1925–1927. 1 indexed citations
15.
Maccubbin, Darbie, et al.. (1993). Immunological responses critical to the therapeutic effects of adriamycin plus interleukin 2 in C57BL/6 mice bearing syngeneic EL4 lymphoma.. PubMed. 5(9). 363–72. 19 indexed citations
16.
Ehrke, M. Jane, et al.. (1988). Species-specific TNF induction of thymocyte proliferation. Cancer Immunology Immunotherapy. 27(2). 103–8. 30 indexed citations
17.
Maccubbin, Darbie, et al.. (1988). Comparison of adriamycin induced immunomodulation with that of the noncardiotoxic anthracycline 5-iminodaunorubicin. International Journal of Immunopharmacology. 10(3). 317–323. 3 indexed citations
18.
Hoffmann, Christian, et al.. (1980). Modification of Mouse Immune Responses Against Allogeneic Tumor by Pretreatment of Antigen with Mitomycin C or X-Irradiation. PubMed. 2(2). 213–223. 4 indexed citations
19.
Ehrke, M. Jane, Sheldon Cohen, & Enrico Mihich. (1978). Selectivity of inhibition by anticancer agents of mouse spleen immune effector functions involved in responses to sheep erythrocytes.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(3). 521–30. 17 indexed citations
20.
Souček, J., M. Jane Ehrke, & Enrico Mihich. (1970). Effects of 4,4'-diacetyldiphenylurea-bis-(guanylhydrazone) on the incorporation of precursors into nucleic acid and protein of leukemia L1210.. PubMed. 30(8). 2187–94. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Livia Di Renzo Breakdown of academic impact, for papers by Françoise Besançon Breakdown of academic impact, for papers by Thuy‐Anh Tran‐Thi Breakdown of academic impact, for papers by Chung‐Her Jenh Breakdown of academic impact, for papers by Long T. Quan Breakdown of academic impact, for papers by David Fischer Breakdown of academic impact, for papers by S Scott Breakdown of academic impact, for papers by Bassam B. Damaj Breakdown of academic impact, for papers by Jean‐Pierre Kolb Breakdown of academic impact, for papers by Gerald Ranges
Rankless by CCL
2026